Related Experiment Video
Updated: Feb 24, 2026
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function
Lawrence Tc Ong1,2, Ueli Nachbur3,4, Dorota Rowczenio5
11 Centre for Immunology, 107640 Westmead Institute for Medical Research , University of Sydney, New South Wales, Australia.
Abstract:
Mutations in the nucleotide binding domain of the PRR, NOD2, are associated with the autoinflammatory diseases Blau syndrome and early-onset sarcoidosis. Current theories suggest that constitutive activation of the NOD2 pathway may be responsible for pathogenesis of these diseases. Here, we report the phenotype of a kindred with Blau syndrome caused by a novel NOD2 mutation (p.E383D). Signaling protein and cytokine expression were examined, and the results of these experiments challenge current theories of constitutive NOD2 activation in the pathophysiology of Blau syndrome.
Insights
Mutations in the NOD2 gene cause Blau syndrome, an autoinflammatory disease. This study challenges the idea that NOD2 pathway overactivation drives the disease, suggesting new insights into its pathophysiology.
Area of Science:
- Immunology
- Genetics
- Autoinflammatory Diseases
Background:
- Nucleotide-binding domain (NBD) mutations in NOD2 are linked to Blau syndrome and early-onset sarcoidosis.
- Existing hypotheses propose constitutive NOD2 pathway activation underlies disease pathogenesis.
Observation:
- A family (kindred) with Blau syndrome due to a novel NOD2 mutation (p.E383D) was studied.
- Expression of signaling proteins and cytokines was analyzed in affected individuals.
Findings:
- The observed signaling protein and cytokine expression patterns challenge the prevailing theory of constitutive NOD2 activation.
- This novel mutation's phenotype provides evidence against a simple model of pathway overactivation.
Implications:
- Findings necessitate a re-evaluation of the molecular mechanisms driving Blau syndrome.
- This research may lead to revised therapeutic strategies targeting the NOD2 pathway in autoinflammatory conditions.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Related Concept Videos
01:33Pleiotropy
01:11Genetic Lingo
01:31Translation
Translation Produces the Building Blocks of Life
Proteins are...
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
02:32Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
02:18Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...